Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2704-2712

  Ceccarelli, Matteo ^a   Bani, Daniele ^a   Cinci, Lorenzo ^a   Nistri, Silvia ^a   Uliva, Caterina ^a   Ragazzo, Elena ^a   Vannacci, Alfredo ^a   Manoni, Marco ^b   Gori, Anna Maria ^a,c   Abbate, Rosanna ^a   Gensini, Gian Franco ^a   Masini, Emanuela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INALCO RSM SpA   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cyclooxygenase 2; Cytokines; Leucocytes; Low molecular weight heparin; Nitric oxide synthase; Pleurisy

Indexed keywords

RATTUS;

EID: 70449663393     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00658.x     Document Type: Article

References (39)

1. Xie WL, Chipman JG, Robertson DL, et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 1991 88 : 2692 2696.
2. Sluiter W, Pietersma A, Lamers JMJ, et al. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanism underlying their expression. J Cardiovasc Pharmacol. 1993 22 : S37 44.
3. Laroux FS, Lefer DJ, Kawachi S, et al. Role of nitric oxide in the regulation of acute and chronic inflammation. Antiox Redox Signal. 2000 2 : 391 396.
4. Johnson KJ, Varani J, Smolen JE. Neutrophil activation and function in health and disease. Immunol Ser. 1992 57 : 1 46.
5. Feuerstein G, Hallenbeck JM. Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol. 1987 27 : 301 313.
6. Tomlinson A, Appleton I, Moore AR, et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol. 1994 113 : 693 698.
7. Guyton JR, Rosenberg RD, Clowes AW, et al. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res. 1980 46 : 625 634.
8. Folkman J. Regulation of angiogenesis: a new function of heparin. Biochem Pharmacol. 1985 34 : 905 909.
9. Au YP, Montgomery KF, Clowes AW. Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circ Res. 1992 70 : 1062 1069.
10. Weiler JM, Edens RE, Linhardt RJ, et al. Heparin and modified heparin inhibit complement activation in vivo. J Immunol. 1992 148 : 3210 3215.
11. Nelson RM, Cecconi O, Roberts WG, et al. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood. 1993 82 : 3253 3258.
12. Attanasio M, Gori AM, Giusti B, et al. Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. Thromb Haemost. 1998 79 : 959 962.
13. Wang JG, Mu JS, Zhu HS, et al. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo. Inflamm Res. 2002 51 : 435 443.
14. Gori AM, Attanasio M, Gazzini A, et al. Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. J Thromb Haemost. 2004 2 : 1657 1662.
15. Gilroy DW, Colville-Nash PR, Willis D, et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999 5 : 698 701.
16. Cuzzocrea S, Mazzon E, Calabro G, et al. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med. 2000 162 : 1859 1866.
17. Cuzzocrea S, Santagati S, Sautebin L, et al. 17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology. 2000 141 : 1455 1463.
18. Cuzzocrea S, Mazzon E, Sautebin L, et al. The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol Med. 2001 7 : 478 487.
19. Cuzzocrea S, Mazzon E, Sautebin L, et al. Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat. Biochem Pharmacol. 2002 63 : 785 795.
20. Cuzzocrea S, McDonald MC, Mazzon E, et al. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol. 2002 63 : 293 304.
21. Cuzzocrea S, Zingarelli B, Hake P, et al. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Bio Med. 1998 24 : 450 459. (Pubitemid 28008790)
22. Tomlinson A, Appleton I, Moore AR, et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol. 1994 113 : 693 698.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 72 : 248 254.
24. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985 14 : 157 167.
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 95 : 351 358.
26. Sautebin L, Ialenti A, Ianaro A, et al. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. Eur J Pharmacol. 1995 286 : 219 222.
27. Goldstein IM, Kaplan HB, Edelson HS, et al. Ceruloplasmin: an acute phase reactant that scavenges oxygen-derived free radicals. Ann N Y Acad Sci. 1982 389 : 368 379.
28. Harada Y, Hatanaka K, Kawamura M, et al. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins. 1996 51 : 19 33.
29. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993 90 : 7240 7244.
30. Matzner Y, Marx G, Drexler R, et al. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost. 1984 52 : 134 137.
31. Tangelder GJ, Arfors KE. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides. Blood. 1991 77 : 1565 1571.
32. Hochart H, Jenkins PV, Smith OP, et al. Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol. 2006 133 : 62 7.
33. Bârzu T, Lormeau JC, Petitou M, et al. Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells. J Cell Physiol. 1989 140 : 538 548.
34. Deepa PR, Varalakshmi P. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative. Int J Cardiol. 2006 106 : 338 347.
35. Norrby K. Low-molecular-weight heparins and angiogenesis. Acta Pathol Microbiol Immunol Scand. 2006 114 : 79 102.
36. Thourani VH, Brar SS, Kennedy TP, et al. Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2000 278 : H2084 93.
37. Szabo C, Wu CC, Gross SS, et al. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol. 1993 250 : 157 160. (Pubitemid 23353073)
38. Akarasereenont P, Bakhle YS, Thiemermann C, et al. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br J Pharmacol. 1995 115 : 401 408.
39. Schulman S. Novel anticoagulant agents: introduction. J Intern Med. 2003 254 : 308 312.